NCT00701779 - Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

Tamsulosin

Dutasteride 0.5mg once daily for one year and tamsulosin 0.4mg administered once daily for 3 months, followed by counseling on flexible dosing of tamsulosin on an as needed basis.

Trial Locations (1)

47713

Research Institute of Deaconess Clinic, Evansville